Rapt Therapeutics (RAPT)
(Delayed Data from NSDQ)
$8.10 USD
+0.30 (3.85%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $8.10 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Earnings News For RAPT
-
RAPT Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
-
RAPT Therapeutics Reports Third Quarter 2023 Financial Results
-
RAPT Therapeutics Reports Second Quarter 2023 Financial Results
-
RAPT Therapeutics Reports First Quarter 2023 Financial Results
-
RAPT Therapeutics Reports Fourth Quarter And Year End Financial Results
-
Rapt Therapeutics (RAPT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
-
Rapt Therapeutics (RAPT) Reports Q3 Loss, Lags Revenue Estimates
-
RAPT Therapeutics Reports Third Quarter 2022 Financial Results
-
Rapt Therapeutics (RAPT) Reports Q2 Loss, Tops Revenue Estimates
-
Rapt Therapeutics (RAPT) Reports Q1 Loss, Tops Revenue Estimates
-
Rapt Therapeutics (RAPT) Reports Q3 Loss, Lags Revenue Estimates
-
Rapt Therapeutics (RAPT) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
-
RAPT THERAPTICS (RAPT) Reports Q2 Loss, Lags Revenue Estimates
-
Analysts Estimate RAPT THERAPTICS (RAPT) to Report a Decline in Earnings: What to Look Out for
-
RAPT THERAPTICS (RAPT) Reports Q1 Loss, Misses Revenue Estimates
-
RAPT THERAPTICS (RAPT) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
-
RAPT THERAPTICS (RAPT) Reports Q4 Loss, Misses Revenue Estimates